Published in Aliment Pharmacol Ther on March 01, 2002
Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol (2005) 1.24
Recent insights into digestive motility in functional dyspepsia. J Gastroenterol (2006) 1.05
Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia. Ther Clin Risk Manag (2007) 0.84
Relationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients. World J Gastroenterol (2005) 0.83
Relationship between antral distension and postprandial symptoms in functional dyspepsia. World J Gastroenterol (2006) 0.79
Effect of duodenal glucose and acute hyperglycemia on rectal perception and compliance in response to tension-controlled rectal distension in healthy humans. Dig Dis Sci (2008) 0.77
Treatment of Functional Dyspepsia. Curr Treat Options Gastroenterol (2003) 0.77
Efficacy and tolerability of levosulipride, domperidone and metoclopramide in patients with non-ulcer functional dyspepsia: a comparative analysis. J Clin Diagn Res (2015) 0.76
Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients. World J Gastroenterol (2015) 0.75
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology (1992) 1.58
Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48
Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol (1994) 1.46
Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol (1990) 1.41
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect Immun (2000) 1.39
Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39
Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38
Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut (2005) 1.29
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology (1997) 1.22
Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem (1989) 1.18
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol (2000) 1.14
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A (1992) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10
Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum (1997) 1.09
Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09
Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07
Gynecomastia during omeprazole therapy. N Engl J Med (1991) 1.07
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br J Pharmacol (2000) 1.04
Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth (2009) 1.03
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol (2002) 1.03
Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00
False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics (1994) 1.00
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99
Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol (1989) 0.98
Upper gastrointestinal motor abnormalities in children with active celiac disease. J Pediatr Gastroenterol Nutr (1995) 0.97
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol (1995) 0.97
Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci (1993) 0.97
Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc Natl Acad Sci U S A (1978) 0.96
Human colonic motility: physiological aspects. Int J Colorectal Dis (1995) 0.95
Edrophonium chloride for testing colonic contractile activity in man. Acta Physiol Scand (1991) 0.95
Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol (2005) 0.94
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. Br J Pharmacol (2001) 0.94
Transition from nutcracker esophagus to diffuse esophageal spasm. Am J Gastroenterol (1985) 0.94
Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture. Immunology (1996) 0.94
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha. Aliment Pharmacol Ther (1999) 0.94
Diagnostic accuracy of bedside ultrasonography in the ICU: feasibility of detecting pulmonary effusion and lung contusion in patients on respiratory support after severe blunt thoracic trauma. Acta Anaesthesiol Scand (2008) 0.94
Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf (2001) 0.93
First results from the XENON10 dark matter experiment at the Gran Sasso National Laboratory. Phys Rev Lett (2008) 0.93
Duodenojejunal motor activity in patients with chronic dyspeptic symptoms. J Clin Gastroenterol (1990) 0.93
Distension-stimulated propagated contractions in human colon. Dig Dis Sci (1994) 0.93
Intestinal pseudoobstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol (1992) 0.92
Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci (1995) 0.92
Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Digestion (1987) 0.92
Impaired colonic motor response to eating in patients with slow-transit constipation. Am J Gastroenterol (1992) 0.92
Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol (1995) 0.91
Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol (1995) 0.91
Human erythrocyte glucose 6-phosphate dehydrogenase. Content of bound coenzyme. Biochem Biophys Res Commun (1974) 0.90
Castleman's disease: an unusual cause of mediastinal mass and anemia. Clin Ter (2002) 0.90
Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study. Aliment Pharmacol Ther (2006) 0.90
Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease. Dig Dis Sci (1997) 0.89
Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone (1996) 0.89
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis (2008) 0.88
Severity scores in respiratory intensive care: APACHE II predicted mortality better than SAPS II. Respir Care (1995) 0.88
Interactions of dendritic cells with fibronectin and endothelial cells. Immunology (1998) 0.88
Axillary nerve injuries--21 cases treated by nerve graft and neurolysis. J Hand Surg Am (1982) 0.88
Oral bile acid treatment and the patient with Zellweger syndrome. Hepatology (1992) 0.87
Colonic motor response to eating: a manometric investigation in proximal and distal portions of the viscus in man. Am J Gastroenterol (1989) 0.87
Prolonged (24-hour) manometric recording of rectal contractile activity in patients with slow transient constipation. Digestion (1991) 0.87
Endoluminal instillation of bisacodyl in patients with severe (slow transit type) constipation is useful to test residual colonic propulsive activity. Digestion (1999) 0.87
Favism: a hemolytic disease associated with increased superoxide dismutase and decreased glutathione peroxidase activities in red blood cells. Eur J Biochem (1984) 0.87
Adenocarcinoma of the duodenal bulb in a young coeliac woman. Ital J Gastroenterol (1993) 0.87
Functional dyspepsia and chronic idiopathic gastric stasis. Role of endogenous opiates. Arch Intern Med (1986) 0.87
Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.86